Differential role for protein kinase C-mediated signaling in the proliferation of medulloblastoma cell lines

International Journal of Oncology

Volumn 12, Issue 4, 1998, Pages 759-768

  Adesina, Adekunle M ^a,b   Dooley, Nora ^b   Yong, Voon Wee ^b   Nalbantoglu, Josephine ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Calphostin; Cyclin dependent kinases; Medulloblastoma; PMA; Primitive neuroectodermal tumors; Protein kinase C isoforms

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALPHOSTIN C; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN P21; PROTEIN P27;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL DIVISION; HUMANS; ISOENZYMES; MEDULLOBLASTOMA; PROTEIN KINASE C; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0031938867     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.4.759     Document Type: Article

References (65)

1. Russell DS and Rubinstein LJ: Pathology of tumors of the central nervous system. 5th edition. Williams & Wilkins, pp251-270, 1989.
2. Ben-Ari Y, Anikszteijn L and Biegestovki P: Protein kinase C modulation of NMDA currents: an important link for LTP induction. Trends Neurosci 15: 333-339, 1992.
3. Saito N, Kikkawa U, Nishizuka Y and Tanaka C: Distribution of protein kinasc C-likc immunoreactive neurons in rat brain. J Neurosci 8: 369-382, 1988.
4. Koda Y, Kobayashi H, Mizki T, Okazaki M, Uczono Y, Yanagihara N, Wa A and Izumi F: Protein kinase C subtypes in tissues derived from neural crest. Brain Res 518: 334-336, 1990.
5. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-613, 1992.
6. Nishizuka Y: The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661-665, 1988.
7. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496, 1995.
8. Ghosh S and Baltimore D: Activation HI vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature 344: 678-682, 1990.
9. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D and Rapp UR: Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364: 249-252, 1993.
10. Young SW, Dickens M and Tavare JM: Activation of mitogen-activated protein kinase by protein kinase C isotypes alpha, beta 1 and gamma but not epsilon. FEBS Lett 384: 181-184, 1996.
11. Malarkey K, McLees A, Paul A, Gould GW and Plein R: The role of protein kinase C in activation and termination of mitogen-activatcd protein kinase activity in angiotensin II-stimulated rat aortic smooth muscle cells. Cell Signal 8: 123-129, 1996.
12. Eldar H, Zisman Y, Ullrich A and Livneh E: Overexpression of protein kinase C α subtype in Swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor. J Biol Chem 265: 13290-13296, 1990.
13. Melloni E, Ponremoli S, Sparastove B, Patrone M, Grossi F, Marks PA and Rifkind RA: Introduction of the ß isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells. Proc Natl Acad Sci USA 87: 4417-4420, 1990.
14. Choi P, Tchou-Wong K and Weinstein IB: Overexpression of protein kinase C in HT 29 colon cancer cells causes growth inhibition and tumor suppression. Mol Cell Biol 10: 4650-4657, 1990.
15. Romanova LY, Alexandrov IA, Schwab G, Hilbert DM, Mushinski JF and Nordan RP: Mechanism of apoptosis suppression by phorbol ester in IL-6 starved murine plasmacytoma: role of PKC modulation and cell cycle. Biochemistry 35: 9900-9996, 1996.
16. Zhu WH and Loh TT: Differential effects of phorbol esters on apoptosis in HL-60 promyelocytic leukemia cells. Biochem Pharmacol 51: 1229-1236, 1996.
17. McGowan K, De Vente J, Carey JO, Ways DK and Pekala PH: Protein kinase C isoform expression during the differentiation of 3T3-L1 preadipocytes: loss of protein kinasc C-alpha isoform correlates with loss of phorbol 12-myristate 13-acetate activation of nuclear factor kappa B and acquisition of the adipocyte phenotype. J Cell Physiol 167: 113-120, 1996.
18. Florin-Christensen J, Florin-Christensen M, Meinardi E and Calle R: Diversity of roles of protein kinase C alpha in the proliferation of Swiss 3T3 cells. Biochem J 315: 513-516, 1996.
19. Baltuch GH, Dooley NP, Rostworowski KM, Villemure J-G and Yong VW: Protein kinase C isoform α Overexpression in C6 glioma cells and its role in cell proliferation. J Neuro-Oncol 24: 241-250, 1995.
20. Mischak H, Pierce JH, Goodnight J, Kananietz MG, Blumberg PM and Mushinski JF: Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-α and -β and not by protein kinase C-ßII, -ε, -ζ, η. J Biol Chem 268: 20110-20115, 1993.
21. Watanabe T, Ono Y, Taniyama Y, Hazama K-, Igarashi K, Ogita K, Kikkawa U and Nishizuka Y: Cell division arrest induced by phorbol ester in CHO overexpressing protein kinase C-O subspecies. Proc Natl Acad Sci USA 89: 10159-10163,1992.
22. Zhou W, Takuwa N, Kumada M and Takuwa Y: Protein kinase C-mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation and cyclin dependent kinases in human vascular endothelial cells. J Biol Chem 268: 23041-23048, 1993.
23. 1->S cell cycle transition. Cell Growth Differ 7: 75-81, 1996.
24. 1/S phase protein kinase. Science 257: 1958-1961, 1992.
25. 1 phase of the human cell cycle. Science 257: 1689-1694, 1992.
26. Matsuchime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato J-Y: D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14: 2066-2076, 1994.
27. Meyerson M and Harlow E: Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 14: 2077-2086, 1994.
28. Retnisky D, Gossen M, Bujard H and Reed SI: Acceleration of the G|/S phase transition by expression of cyclins D1 and E with an induciblc system. Mol Cell Biol 14: 1669-1679, 1994.
29. Ewen ME, Sluss HK, Whitehouse LL and Livingston DM: TGF ß inhibition of cdk4 kinase is linked to cell cycle arrest. Cell 74: 1009-1020, 1993.
30. Koff A, Ohtsuki M, Polyak K, Roberts JM and Massague J: Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-ß. Science 260: 536-539, 1993.
31. Xiong Y, Hannon GJ, Zhand H, Caso D, Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704, 1993.
32. Xiong Y, Xhang H and Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 505-514, 1992.
33. Harper JW, Adami GR, Wei N, Keymarsi K and Elledge SJ: The cdk interacting protein cipl is a potent inhibitor of G1 cyclin dependent kinases. Cell 75: 805-816, 1993.
34. kip1, a cyclin-cdk inhibitor links transforming growth factor-ß and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22, 1994.
35. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P and Massague J: Cloning of p27kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extra-cellular antimitogenic signals. Cell 78: 59-66, 1994.
36. Reynisdottie I, Polyak K, Iavarone A and Massague J: Kip/cip and INK4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF ß. Genes Dev 9: 1831-1845, 1995.
37. INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371: 257-261, 1994.
38. Ewen ME: p53 dependent response of cdk4 synthesis in transforming growth factor-beta-induced G1 cell cycle arrest. J Lab Clin Med 128: 355-360, 1996.
39. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: Wafl, a potential mediator of p53 tumor suppressor. Cell 75: 817-825, 1993.
40. Dulic V, Kaufman WK, Wilson SJ, Tlsty TD, Lees E, Elledge SJ and Reed SI: p53 dependent inhibition of cyclin dependent kinase activity in human fibroblast during radiation induced G1 arrest. Cell 76: 1013-1023, 1994.
41. Ravitz MJ, Yan S, Dolce C, Kinniburgh AJ and Wenner CE: Differential regulation of p27 and cyclin D1 by TGF ß and RGF in C3H.10T1/2 mouse fibroblasts. J Cell Physiol 168: 510-520, 1996.
42. Fuse T, Yamada K, Kato T and Nakanishi M: Heat shock-mediated cell cycle arrest is accompanied by induction of p21 cki. Biochem Biophys Res Commun 225: 759-763, 1996.
43. Jacobsen PF, Jenkyn DJ and Papadimitriou JM: Establishment of a human medulloblastoma cell line and its heterotrans-plantation into nude mice. J Neuropathol Exp Neurol 44: 472-485, 1985.
44. He X, Med MS, Skapek SX, Wikstrand CJ, Friedman HS, Trojanowski JQ, Kemshead JT, Coakham HB, Bigner SH and Bigner DD: Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts. J Neuropathol Exp Neurol 48: 48-68, 1989.
45. Chomczynski P and Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
46. Yong VW, Dooley NP and Noble PG: Protein kinase C in cultured adult human oligodendrocytes: a potential role for isoform alpha as a mediator of process outgrowth. J Neurosci Res 39: 83-86, 1994.
47. Sambrook J, Fritsch EF and Maniatis T: Molecular cloning, a laboratory manual. 2nd edition. Cold Spring Harbor Laboratory Press, pp18.62-18.75, 1989.
48. Llosas MD, Batlle E, Coll O, Skoudy A, Fabre M and Garcia de Herreras A: Evidence for a role of conventional protein kinase C alpha in the control of homotypic contacts and cell scattering of HT-29 human intestinal cells. Biochem J 315: 1949-1964, 1996.
49. Saylors RL III, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B and Brodeur GM: Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51: 4721-4723, 1991.
50. 28k defines distinct neuronal types in the developing human cerebellar cortex. J Neuropathol Exp Neurol 52: 655-666, 1993.
51. Yachnis AT, Rorke LB, Lee VM-Y and Trojanowski JQ: Expression of neuronal and glial polypeptides during histogenesis of the human cerebellar cortex including observation on the dentate nucleus. J Comp Neurol 334: 356-369, 1993.
52. Segal RA, Goumnerova LC, Kwon YK, Stiles CD and Pomeroy SL: Expression of neurotrophin receptor trk C is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci US A 91: 12867-12871, 1994.
53. Bernards R: N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma. EMBO J 10: 1119-1125, 1991.
54. Borner C, Guadagno SN, Hsiao WW-L, Fabbro D, Barr M and Weinstein IB: Expression of four protein kinase C isoforms in rat fibroblasts. J Biol Chem 267: 12900-12910, 1992.
55. Hsiao W-LW, Housey GM, Johnson MD and Weinstein IB: Cells that overproduce protein kinase C are more susceptible to transformation by an activated H-ras oncogene. Mol Cell Biol 9: 2641-2647, 1989.
56. Krauss RS, Housey GM, Johnson MD and Weinstein IB: Disturbances in growth control and gene expression in a C3H.10T1/2 cell line that stably overexpresses protein kinase C. Oncogene 4: 991-998, 1989.
57. Nishikawa M, Komada F, Uemura Y, Hidaka H and Shirakawa S: Decreased expression of type II protein kinase C in HL-60 variant cells resistant to induction of cell diffrentiation by phorbol ester. Cancer Res 50: 621-626, 1990.
58. Sposi NM, Bottero L, Cossu G, Russo G, Testa U and Peschle C: Expression of protein kinase C genes during ontogenic development of central nervous system. Mol Cell Biol 9: 2284-2288, 1989.
59. Chalfant CE, Mischak H, Watson JE, Winkler BC, Goodnight J, Farese RV and Cooper DR: Regulation of alternative splicing of protein kinase C beta by insulin. J Biol Chem 270: 13326-13332, 1995.
60. O'Driscoll KR, Teng KK, Fabbro D, Greene LA and Weinstein IB: Selective translocation of protein kinase C-o in PC12 cells during nerve growth factor induced neuritogenesis. Mol Cell Biol 6: 449-458, 1995.
61. Akama Y, Yasui W, Kuniyasu H, Hokozaki H, Akagi M, Tahara H, Ishikawa T and Tahara E: Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Jpn J Cancer Res 87: 824-830, 1996.
62. Zeng YX, Somasundaram K and El-Deiry WS: AP2 inhibits cancer cell growth and activates p21 wafl/cipl expression. Nat Genet 15: 78-82, 1997.
63. Lee MH, Nikolic M, Baptista CA, Lai E, Isai LH and Massaguc J: The brain specific activator p35 allows cdk5 to escape inhibition by p27kip1 in neurons. Proc Natl Acad Sci USA 93: 3259-3263, 1996.
64. Adesina AM, Dunn T and Nalbantoglu J: The pattern of p27kip1 expression shows a relationship between focal inhibition of proliferation and differentiation in medulloblastoma. Ph.D. thesis, McGill University, 1997.
65. Fer ML, Rivkin M, Tasch M, Porter P, Crow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutto RM, Kaushansky K and Roberts JM: A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis and female sterility in p27(kip1)-deficient mice. Cell 85: 733-744, 1996.